Tirzepatide, in contrast, is already FDA-approved and available as Mounjaro (for type 2 diabetes) and Zepbound (for obesity)
Head on over to our section on does CareFirst cover weight loss medication
The molecule also validated GLP-1 drugs at a commercial scale that helped define the market now contested by Lillys tirzepatide, a dual GIP/GLP-1 receptor agonist
Across GLP-1 trials, about 60% of lost weight returns within a year and about 75% over the longer regain curve. Continued treatment has stronger evidence than complete withdrawal
In the gastrointestinal tract, current studies have identified that metformin effects glucose uptake and absorption, influences GLP-1 secretion, modulates immune homeostasis, and regulates the gut microbiota, detailed information was drawn in Figure 1